• OPEN AN ACCOUNT
Indian Indices
Sensex
76,909.68 -325.78
( -0.42%)
Global Indices
Nasdaq
53,360.44 -120.34
(-0.23%)
Dow Jones
7,713.14 -52.92
(-0.68%)
Hang Seng
65,335.94 -2,124.79
(-3.15%)
Nikkei 225
10,747.45 19.41
(0.18%)
Forex
USD-INR
95.60 0.07
(0.07%)
EUR-INR
110.76 0.24
(0.21%)
GBP-INR
129.56 0.29
(0.22%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Bacil Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524516
INE711D01018
17.5524281
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
25.76
17.01
EPS(TTM)
Face Value()
Div & Yield %
0.46
10
0
 

Bacil Pharma reports standalone net loss of Rs 0.02 crore in the June 2026 quarter
Aug 12,2026
Net loss of Bacil Pharma reported to Rs 0.02 crore in the quarter ended June 2026 as against net profit of Rs 0.67 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 and during the previous quarter ended June 2025.